Comparison of SPECT/CT Perfusion and Volumetric CT Volume
NCT ID: NCT06600204
Last Updated: 2025-06-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2024-11-30
2025-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
CT Perfusion Scans for Assessment of Lung Cancer Before and After Chemo +/- Radiotherapy
NCT00188214
Pulmonary Ventilation/Perfusion Imaging for the Prediction of Postoperative Residual Pulmonary Function
NCT03357094
Post-Surgical Non-Small Cell Lung Cancer (NSCLC) Follow-up
NCT00198341
Post-Operative Prediction of PulmonarY Function
NCT06494254
Computed Tomography (CT) Perfusion Imaging of Lung Cancer
NCT00905801
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Among patients for whom it is indicated, the preoperative assessment involves the evaluation of pulmonary function and the prediction of postoperative pulmonary function in order to validate the feasibility of surgery. To do this, several methods have been described: anatomical methods (segment counting), radiological imaging methods (CT, DECT, perfusion MRI), and nuclear imaging methods (planar perfusion and/or ventilation pulmonary scintigraphy, SPECT pulmonary perfusion scintigraphy), some of which are hybrid (SPECT/CT). The use of SPECT/CT to predict postoperative pulmonary function is routinely practiced, and its reliability, accuracy, and concordance with measured postoperative pulmonary function are well demonstrated for pneumectomy and lobectomy. For more conservative surgeries, the data in the literature remain uncertain. However, being able to predict pulmonary function is essential, both to justify the feasibility of the intervention, but also to target the most fragile patients and intensify their postoperative respiratory rehabilitation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients who underwent a single or multiple segmentectomy
Patients who underwent a single or multiple segmentectomy in the thoracic surgery department of the Nancy University Hospital between April 2021 and July 2023
lung scintigraphy
Use the SPECT/CT to predict pulmonary function
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
lung scintigraphy
Use the SPECT/CT to predict pulmonary function
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients having benefited from a single or multiple segmentectomy within the thoracic surgery department of the CHRU of Nancy during the period April 2021 to June 2023
* Patients having a complete pre-operative assessment (SPECT/CT, volumetric CT and EFR)
* Patients having 2 post-operative assessments (respiratory functional exploration (EFR) at approximately 1 month post-operatively and 6 months post-operatively).
Exclusion Criteria
* Patient who did not have a complete preoperative assessment (SPECT/CT or volumetric CT or missing respiratory functional exploration EFR).
* Patient who did not have a complete postoperative assessment (missing respiratory functional exploration EFR at 6 months).
NB: the absence of respiratory functional exploration EFR at 1 month postoperatively is not an exclusion criterion
18 Years
95 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Central Hospital, Nancy, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Antoine VERGER
Principal investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHRU of NANCY
Vandœuvre-lès-Nancy, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Retrospective study
Identifier Type: OTHER
Identifier Source: secondary_id
2024PI070
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.